Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,786,648
-
Share change
-
-1,766,062
-
Total reported value
-
$5,571,004
-
Put/Call ratio
-
26%
-
Price per share
-
$2.00
-
Number of holders
-
38
-
Value change
-
-$5,820,776
-
Number of buys
-
19
-
Number of sells
-
20
Institutional Holders of Fortress Biotech, Inc. - COM NEW (FBIO) as of Q1 2024
As of 31 Mar 2024,
Fortress Biotech, Inc. - COM NEW (FBIO) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,786,648 shares.
The largest 10 holders included
Rosalind Advisors, Inc., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Nantahala Capital Management, LLC, SHIKIAR ASSET MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, GSA CAPITAL PARTNERS LLP, Corient Private Wealth LLC, ENVESTNET ASSET MANAGEMENT INC, and BlackRock Inc..
This page lists
38
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.